102 employees
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
2017
$60M
from 4 investors over 4 rounds
Tarsus Pharmaceuticals, Inc. raised $60M on January 8, 2020
Investors: Aperture Venture Partners, Frazier Healthcare Partners, Visionary Venture Fund and Flying L Partners